Literature DB >> 34173040

Applying the thresholds for clinical importance for fourteen key domains of the EORTC QLQ-C30: a latent class analysis of cancer survivors.

Laura Keaver1, Christopher McLaughlin2.   

Abstract

A person's quality of life is impacted from the beginning of their oncology experience. One of the most common tools to measure quality of life is the EORTC QLQ-C30. The absolute scores it produces can be difficult to interpret in the clinical setting, and thresholds to help identify those who require intervention have recently been introduced. The aim of this research was to identify heterogeneity of these thresholds for clinical importance using latent class analysis in cancer survivors (those undergoing and those who have completed treatment) attending a hospital in the northwest of Ireland. We identified 3 distinct classes of cancer survivors, using Mplus 6.11: high clinical impact (13.9%), compromised physical function (40.3%) and low clinical impact (45.9%). The compromised physical function group were slightly more likely to be older (OR = 1.042, p < .05, CI = 1.000-1.086), not employed (OR = 8.347, p < .01, CI = 2.092-33.305), have lower PG-SGA scores (OR = .826, p < .001, CI = .755-.904), and not have been diagnosed in the last 2 years (OR = .325, p < .05, CI = .114-.923) compared to the high clinical impact group. The low clinical impact group were more likely to be female (OR = 3.288, p < .05, CI = 1.281-1.073), not employed (OR = 10.129, p < .01, CI = 2.572-39.882), have a lower BMI (OR = .921, p < .05, CI = .853-.994), and lower PG-SGA scores (OR = .656, p < .001, CI = .573-.750) than the high clinical impact group. Functional and symptom issues impact on quality of life, and therefore, identifying those of clinical importance is crucial for developing supportive care strategies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Clinical importance; Functioning; Quality of life; Symptom burden; Thresholds

Mesh:

Year:  2021        PMID: 34173040      PMCID: PMC8232988          DOI: 10.1007/s00520-021-06292-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  41 in total

Review 1.  The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual.

Authors:  Lisa M Wintner; Monika Sztankay; Neil Aaronson; Andrew Bottomley; Johannes M Giesinger; Mogens Groenvold; Morten Aa Petersen; Lonneke van de Poll-Franse; Galina Velikova; Irma Verdonck-de Leeuw; Bernhard Holzner
Journal:  Eur J Cancer       Date:  2016-10-06       Impact factor: 9.162

2.  Health-related quality of life in lung cancer survivors: Latent class and latent transition analysis.

Authors:  Kelly M Kenzik; Michelle Y Martin; Mona N Fouad; Maria Pisu
Journal:  Cancer       Date:  2015-01-06       Impact factor: 6.860

Review 3.  Implementation of Patient-Reported Outcomes in Routine Medical Care.

Authors:  Ethan Basch; Lisa Barbera; Carolyn L Kerrigan; Galina Velikova
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

4.  Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors.

Authors:  D Cella; K Davis; W Breitbart; G Curt
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

Review 5.  Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations.

Authors:  T Luckett; M T King; P N Butow; M Oguchi; N Rankin; M A Price; N A Hackl; G Heading
Journal:  Ann Oncol       Date:  2011-02-21       Impact factor: 32.976

6.  Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences.

Authors:  Nina Gulbrandsen; Marianne J Hjermstad; Finn Wisløff
Journal:  Eur J Haematol       Date:  2004-03       Impact factor: 2.997

7.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

Review 8.  The prognostic significance of patient-reported outcomes in cancer clinical trials.

Authors:  Carolyn C Gotay; Crissy T Kawamoto; Andrew Bottomley; Fabio Efficace
Journal:  J Clin Oncol       Date:  2008-01-28       Impact factor: 44.544

9.  Physical function in patients with cancer: psychometric characteristics and clinical usefulness of a physical performance test battery.

Authors:  Maureen J Simmonds
Journal:  J Pain Symptom Manage       Date:  2002-10       Impact factor: 3.612

10.  Quality of life after cancer-How the extent of impairment is influenced by patient characteristics.

Authors:  Elisabeth Peters; Laura Mendoza Schulz; Monika Reuss-Borst
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.